Posted On: 01/09/2014 2:22:00 PM
Post# of 145149
$REGN Up to date company activities and other important information about $REGN
$REGN
DD Notes ~ http://www.ddnotesmaker.com/REGN
##### recent news/filings ~ source: finance.yahoo.com
Thu, 09 Jan 2014 00:52:30 GMT ~ Why the Risk/Reward Ratio Looks Great for Regeneron Pharmaceuticals Inc.
- There’s risk, but there could be vast rewards for Regeneron Pharmaceuticals Inc.
read full: http://www.fool.com/investing/general/2014/01...lnk0000001
*********************************************************
Tue, 07 Jan 2014 23:00:00 GMT ~ Bull rally still have room to run?
- Mad Money host Jim Cramer discusses how the return of some classic growth stocks into the green is a sign the bull rally may not be over.
read full: http://video.cnbc.com/gallery/?video=30002336...;par=yahoo
*********************************************************
Tue, 07 Jan 2014 20:31:00 GMT ~ Celgene Gets Infusion from Investors, Analysts Following Goldman Downgrade
- If news about the biotech sector grabbed your attention yesterday, the saga continues as investors and some analysts are standing by the sector despite yesterday's downgrade by Goldman Sachs. One winner this afternoon is Celgene (CELG) with shares up 1.3% following yesterday's 4.2% drop. We recapped the highlights from yesterday in a Barron's Take after Goldman downgraded the biotech sector and Celgene was cut to Sell from Neutral by the firm based on valuation and possible headwinds with its products. Despite the stamp of uncertainty from the cool kids at Goldman, Celgene is up, and RBC analyst Michael J. Yee maintained an Outperform rating and $190 price target while lifting fourth quarter estimates in a note today where he acknowledged that it's a "reasonable thing" for some to speculate whether or not big performers can repeat their streak in the following year.
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
Tue, 07 Jan 2014 15:14:00 GMT ~ Everything You Need to Know About Biotech M&A in a Single Chart
- M&A deal flow was higher in 2013 despite higher sector valuations, which might portend even more deals in 2014.
read full: http://www.thestreet.com/story/12214559/1/eve..._ven=YAHOO
*********************************************************
Tue, 07 Jan 2014 13:44:00 GMT ~ BioPharma Catalyst And Investment Pick In Focus: Progenics
- Written by Scott Matusow Catalyst events for developmental pharmas usually mean the associated stock prices see good appreciation in the period leading up to these events. As we get within a few days to ...
read full: http://seekingalpha.com/article/1931161-bioph...urce=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=REGN&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=REGN&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/REGN/company-info
Ticker: $REGN
OTC Market Place: Not Available
CIK code: 0000872589
Company name: Regeneron Pharmaceuticals, Inc.
Incorporated In: NY, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/REGN/filings
Latest financials: http://www.otcmarkets.com/stock/REGN/financials
Latest news: http://www.otcmarkets.com/stock/REGN/news - http://finance.yahoo.com/q/h?s=REGN+Headlines
Major holdings: http://data.cnbc.com/quotes/REGN/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=REGN+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/REGN.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=REGN
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Regeneron+Pharmace...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
http://www.pennystocktweets.com/stocks/profile/REGN
##### last known share structure ~ source: otcmarkets.com
Market Value: $28,719,267,801 a/o Jan 08, 2014
Shares Outstanding: 97,389,765 a/o Oct 28, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/REGN
$REGN
DD Notes ~ http://www.ddnotesmaker.com/REGN
##### recent news/filings ~ source: finance.yahoo.com
Thu, 09 Jan 2014 00:52:30 GMT ~ Why the Risk/Reward Ratio Looks Great for Regeneron Pharmaceuticals Inc.
- There’s risk, but there could be vast rewards for Regeneron Pharmaceuticals Inc.
read full: http://www.fool.com/investing/general/2014/01...lnk0000001
*********************************************************
Tue, 07 Jan 2014 23:00:00 GMT ~ Bull rally still have room to run?
- Mad Money host Jim Cramer discusses how the return of some classic growth stocks into the green is a sign the bull rally may not be over.
read full: http://video.cnbc.com/gallery/?video=30002336...;par=yahoo
*********************************************************
Tue, 07 Jan 2014 20:31:00 GMT ~ Celgene Gets Infusion from Investors, Analysts Following Goldman Downgrade
- If news about the biotech sector grabbed your attention yesterday, the saga continues as investors and some analysts are standing by the sector despite yesterday's downgrade by Goldman Sachs. One winner this afternoon is Celgene (CELG) with shares up 1.3% following yesterday's 4.2% drop. We recapped the highlights from yesterday in a Barron's Take after Goldman downgraded the biotech sector and Celgene was cut to Sell from Neutral by the firm based on valuation and possible headwinds with its products. Despite the stamp of uncertainty from the cool kids at Goldman, Celgene is up, and RBC analyst Michael J. Yee maintained an Outperform rating and $190 price target while lifting fourth quarter estimates in a note today where he acknowledged that it's a "reasonable thing" for some to speculate whether or not big performers can repeat their streak in the following year.
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
Tue, 07 Jan 2014 15:14:00 GMT ~ Everything You Need to Know About Biotech M&A in a Single Chart
- M&A deal flow was higher in 2013 despite higher sector valuations, which might portend even more deals in 2014.
read full: http://www.thestreet.com/story/12214559/1/eve..._ven=YAHOO
*********************************************************
Tue, 07 Jan 2014 13:44:00 GMT ~ BioPharma Catalyst And Investment Pick In Focus: Progenics
- Written by Scott Matusow Catalyst events for developmental pharmas usually mean the associated stock prices see good appreciation in the period leading up to these events. As we get within a few days to ...
read full: http://seekingalpha.com/article/1931161-bioph...urce=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=REGN&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=REGN&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/REGN/company-info
Ticker: $REGN
OTC Market Place: Not Available
CIK code: 0000872589
Company name: Regeneron Pharmaceuticals, Inc.
Incorporated In: NY, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/REGN/filings
Latest financials: http://www.otcmarkets.com/stock/REGN/financials
Latest news: http://www.otcmarkets.com/stock/REGN/news - http://finance.yahoo.com/q/h?s=REGN+Headlines
Major holdings: http://data.cnbc.com/quotes/REGN/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=REGN+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/REGN.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=REGN
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Regeneron+Pharmace...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
http://www.pennystocktweets.com/stocks/profile/REGN
##### last known share structure ~ source: otcmarkets.com
Market Value: $28,719,267,801 a/o Jan 08, 2014
Shares Outstanding: 97,389,765 a/o Oct 28, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/REGN
(0)
(0)
